Literature DB >> 23050777

Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study.

Roopa Kanakatti Shankar1, Catherine Pihoker, Lawrence M Dolan, Debra Standiford, Angela Badaru, Dana Dabelea, Beatriz Rodriguez, Mary Helen Black, Giuseppina Imperatore, Andrew Hattersley, Sian Ellard, Lisa K Gilliam.   

Abstract

BACKGROUND: Neonatal diabetes mellitus (NDM) is defined as diabetes with onset before 6 months of age. Nearly half of individuals with NDM are affected by permanent neonatal diabetes mellitus (PNDM). Mutations in KATP channel genes (KCNJ11, ABCC8) and the insulin gene (INS) are the most common causes of PNDM.
OBJECTIVE: To estimate the prevalence of PNDM among SEARCH for Diabetes in Youth (SEARCH) study participants (2001-2008) and to identify the genetic mutations causing PNDM.
METHODS: SEARCH is a multicenter population-based study of diabetes in youth <20 yr of age. Participants diagnosed with diabetes before 6 months of age were invited for genetic testing for mutations in the KCNJ11, ABCC8, and INS genes.
RESULTS: Of the 15,829 SEARCH participants with diabetes, 39 were diagnosed before 6 months of age. Thirty-five of them had PNDM (0.22% of all diabetes cases in SEARCH), 3 had transient neonatal diabetes that had remitted by 18 months and 1 was unknown. The majority of them (66.7%) had a clinical diagnosis of type1 diabetes by their health care provider. Population prevalence of PNDM in youth <20 yr was estimated at 1 in 252 000. Seven participants underwent genetic testing; mutations causing PNDM were identified in five (71%), (two KCNJ11, three INS).
CONCLUSIONS: We report the first population-based frequency of PNDM in the US based on the frequency of PNDM in SEARCH. Patients with NDM are often misclassified as having type1 diabetes. Widespread education is essential to encourage appropriate genetic testing and treatment of NDM.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050777      PMCID: PMC4101463          DOI: 10.1111/pedi.12003

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  27 in total

1.  HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months.

Authors:  Emma L Edghill; Rachel J Dix; Sarah E Flanagan; Polly J Bingley; Andrew T Hattersley; Sian Ellard; Kathleen M Gillespie
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

2.  The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.

Authors:  Angela D Liese; Ralph B D'Agostino; Richard F Hamman; Patrick D Kilgo; Jean M Lawrence; Lenna L Liu; Beth Loots; Barbara Linder; Santica Marcovina; Beatriz Rodriguez; Debra Standiford; Desmond E Williams
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

3.  Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.

Authors:  Juraj Stanik; Daniela Gasperikova; Magdalena Paskova; Lubomir Barak; Jana Javorkova; Emilia Jancova; Miriam Ciljakova; Peter Hlava; Jozef Michalek; Sarah E Flanagan; Ewan Pearson; Andrew T Hattersley; Sian Ellard; Iwar Klimes
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

4.  Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.

Authors:  A S Slingerland; R Nuboer; M Hadders-Algra; A T Hattersley; G J Bruining
Journal:  Diabetologia       Date:  2006-09-19       Impact factor: 10.122

5.  Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

Authors:  Ewan R Pearson; Isabelle Flechtner; Pål R Njølstad; Maciej T Malecki; Sarah E Flanagan; Brian Larkin; Frances M Ashcroft; Iwar Klimes; Ethel Codner; Violeta Iotova; Annabelle S Slingerland; Julian Shield; Jean-Jacques Robert; Jens J Holst; Penny M Clark; Sian Ellard; Oddmund Søvik; Michel Polak; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

6.  KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Authors:  Anna L Gloyn; Catherine Diatloff-Zito; Emma L Edghill; Christine Bellanné-Chantelot; Sylvie Nivot; Régis Coutant; Sian Ellard; Andrew T Hattersley; Jean Jacques Robert
Journal:  Eur J Hum Genet       Date:  2006-05-03       Impact factor: 4.246

7.  Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.

Authors:  Meena Rafiq; Sarah E Flanagan; Ann-Marie Patch; Beverley M Shields; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2007-11-19       Impact factor: 19.112

8.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

9.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

Authors:  Andrey P Babenko; Michel Polak; Hélène Cavé; Kanetee Busiah; Paul Czernichow; Raphael Scharfmann; Joseph Bryan; Lydia Aguilar-Bryan; Martine Vaxillaire; Philippe Froguel
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

Review 10.  Neonatal diabetes mellitus: a disease linked to multiple mechanisms.

Authors:  Michel Polak; Hélène Cavé
Journal:  Orphanet J Rare Dis       Date:  2007-03-09       Impact factor: 4.123

View more
  24 in total

Review 1.  DNA methylation and its role in the pathogenesis of diabetes.

Authors:  Amita Bansal; Sara E Pinney
Journal:  Pediatr Diabetes       Date:  2017-05       Impact factor: 4.866

2.  Genetic Counseling for Diabetes Mellitus.

Authors:  Stephanie A Stein; Kristin L Maloney; Toni I Pollin
Journal:  Curr Genet Med Rep       Date:  2014-06-01

3.  Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.

Authors:  S Fazeli Farsani; P C Souverein; J A Overbeek; M M J van der Vorst; C A J Knibbe; R M C Herings; A de Boer; A K Mantel-Teeuwisse
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

Review 4.  Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes.

Authors:  Ming Lu; Changhong Li
Journal:  Ann N Y Acad Sci       Date:  2017-10-16       Impact factor: 5.691

Review 5.  Monogenic diabetes: the impact of making the right diagnosis.

Authors:  Anastasia G Harris; Lisa R Letourneau; Siri Atma W Greeley
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

6.  Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry.

Authors:  H U Irgens; J Molnes; B B Johansson; M Ringdal; T Skrivarhaug; D E Undlien; O Søvik; G Joner; A Molven; P R Njølstad
Journal:  Diabetologia       Date:  2013-04-27       Impact factor: 10.122

7.  The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones.

Authors:  Carrie R Sowers; Rong Wang; Rebecca A Bourne; Barbara C McGrath; Jingjie Hu; Sarah C Bevilacqua; James C Paton; Adrienne W Paton; Sophie Collardeau-Frachon; Marc Nicolino; Douglas R Cavener
Journal:  J Biol Chem       Date:  2018-02-14       Impact factor: 5.157

8.  Prematurity and Genetic Testing for Neonatal Diabetes.

Authors:  Rachel E J Besser; Sarah E Flanagan; Deborah G J Mackay; I K Temple; Maggie H Shepherd; Beverley M Shields; Sian Ellard; Andrew T Hattersley
Journal:  Pediatrics       Date:  2016-08-18       Impact factor: 7.124

9.  Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents.

Authors:  Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Catherijne A J Knibbe; Anthonius de Boer; Aukje K Mantel-Teeuwisse
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

10.  Uncommon Presentations of Diabetes: Zebras in the Herd.

Authors:  Karen L Shidler; Lisa R Letourneau; Lucia M Novak
Journal:  Clin Diabetes       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.